Table: begin end state 1 35 cytoplasmic 36 56 transmembrane 57 68 non-cytoplasmic 69 111 transmembrane 112 116 non-cytoplasmic 117 140 transmembrane 141 146 cytoplasmic 147 164 transmembrane 165 184 non-cytoplasmic 185 207 transmembrane 208 235 cytoplasmic 236 260 transmembrane 261 266 non-cytoplasmic 267 285 transmembrane 286 290 cytoplasmic 291 310 transmembrane 311 316 non-cytoplasmic 317 335 transmembrane 336 340 cytoplasmic
Input: >WP_011601464.1 NCBI__GCF_000058485.1:WP_011601464.1 MSTTDTAATSEATRVTGRDSAGPTKRSGRIIPRLGLDRFSGLYVLAALIIAYGIWLPDTF LTSQTARSVADGQAIAAIVALALVVPLAAGVFDLSVAATLGFSVCLVAWLQGHHVNAILS VLTAVAAGIVIGAVNSLVIIVLRVNSFIGTLGMGSLLAAGSYWITDGQTLIKGFSPDLLK AGRAQPAGIPVTVWYLVGIALVLWFVLEYTPVGRYFYAVGANPQASRLAGLRVDRLVARS LILAGFLSALGGAILAAKLGLGSPDVGPPYLLPAFSAAFLGATQIKSGRVNVLGTLVAVY LLGVGVKGLQLAGAPSYVGDLFNGAALIIAVALAARTSRK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server